Happy Thursday! The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023. Their reasoning? Insufficient evidence on whether it causes harm to humans. Meanwhile, hundreds of thousands of people have used BPC-157, including many of you reading this right now. And most of you walked away with zero adverse events and a healed injury. But as of now, we have no documented way to verify the safety and efficacy of some of the most common and effective peptides. Well, hopefully that’s about to change. The Project I've been working on something behind the scenes with a team of heavy hitters that I'm finally ready to share with you. It's called the Peptide Safety Initiative. The FDA says there isn't enough human safety data on BPC-157 to justify allowing compounding pharmacies to produce it. The published clinical data are razor-thin. One small pilot study. A couple of retrospective case reviews. No large-scale human trials. But what does the FDA not have access to? Your experience. The real-world experience of the thousands of people who have used BPC-157 for gut healing, tendon repair, joint recovery, post-surgical rehab, and everything in between. That gap between what regulators see on paper and what our community has experienced firsthand is the entire problem. So we built a tool to close that gap. The Peptide Safety Initiative We created a structured reporting platform where you can document your personal experience with BPC-157. The data gets aggregated and de-identified. Then it goes directly to the doctors and researchers working with the FDA on peptide reclassification. This is a real-world evidence collection effort modeled after the kind of data regulatory bodies actually take seriously. There is a commission currently reviewing the Category 2 designation for several peptides. The doctors on that commission need volume. They need to show the FDA that real humans have used this compound, here's what happened, and here's the safety profile across a large population.

Peptide R is retatrutide and it’s all the rave right now. Triple receptor agonist, GLP-1, GIP, and glucagon. That glucagon action is what sets it apart from everything else out there. Better body composition, muscle sparing while you're cutting, steady energy, allows you to still eat. Peptide-T is tirzepatide and it's the appetite crusher. If food noise is your main problem, tirz is brutal in the best way. If you're new to GLPs this is a solid starting point before you step up to reta. Glutathione is one of the most underrated things in the stack. Master antioxidant, liver support, skin benefits, and it's especially important if you're running other compounds hard. It's protective, not a growth promoter, so it's also one of the few things I feel comfortable recommending across basically every situation including cancer history. Glow is GHK-Cu plus BPC-157 plus TB-500 in one blend. That's the healing trifecta. BPC works locally on whatever tissue you're trying to repair, TB-500 works systemically, and GHK-Cu adds collagen support and skin benefits on top of everything. If you've got a nagging injury this is what you want. GHK-Cu on its own is for people who want to target skin and collagen specifically. Anti-aging, wound healing, scar reduction. Fair warning though, it is spicy. Dilute it with 3ml of BAC water and inject slow. It could burn at injection site.